MEPRIMET MV2 TABLET

Product Description

MEPRIMET MV2 TABLET is a triple-combination oral antidiabetic medication designed to offer comprehensive blood sugar control in Type 2 Diabetes Mellitus. It combines the benefits of Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.2mg)three well-established anti-diabetic agents that work synergistically to improve insulin sensitivity, reduce glucose absorption, and stimulate insulin secretion.This formulation is ideal for medical distributors, hospital pharmacies, and bulk medicine suppliers looking for high-demand diabetes care products.Key Benefits: Multi-targeted approach to Type 2 diabetes management Glimepiride enhances insulin secretion, Metformin improves insulin resistance, and Voglibose slows carbohydrate absorption Sustained-release formula for better glycemic control and patient adherence Manufactured under GMP & ISO-certified facilities ensuring quality and safety Applications: Effective in managing postprandial and fasting blood glucose levels Recommended in chronic Type 2 diabetes cases Prescribed by endocrinologists, general practitioners, and diabetologists Why Choose MEPRIMET MV2 TABLET? High-demand anti-diabetic combination with proven efficacy Attractive for bulk buying, retail chains, and B2B pharmaceutical sourcing Available for pan-India distribution and OEM/third-party manufacturing